跳至主要内容
临床试验/TCTR20210929004
TCTR20210929004尚未招募2 期

Dosimetric and Clinical Outcomes of Hyaluronic Acid Spacer in Phase II Randomized Controlled Trial in Cervical Cancer

Ratchadapiseksompotch Research Fund0 个研究点目标入组 38 人开始时间: 2021年9月29日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
Female

入选标准

  • 1. Positive biopsy showing squamous cell carcinoma, adenocarcinoma, or adenosquamous cell carcinoma of the uterine cervix 2. Cancer of the cervix is considered suitable for curative treatment with definitive radio-(chemo)therapy

排除标准

  • 1. Posterior vaginal involvement 2. Other primary malignancies except basal cell carcinoma of the skin 3. Small cancer neuroendocrine cancer, melanoma, and other rare cancers in the cervix 4. Rectal invasion 5. Metastatic disease above and beyond the retroperitoneal para-aortic L1-L2 interspace 6. Previous pelvic or abdominal radiotherapy 7. Previous total or partial hysterectomy 8. Contraindications to MRI 10. Coagulopathy

研究者

发起方
Ratchadapiseksompotch Research Fund

相似试验